Clinical Trials
3 trialsNCT06152731 2025-09-17
HERO
Centre Francois Baclesse
Phase 2 Recruiting
NCT05732129 2023-02-24
The Efficacy and Safety of Fluzoparib Plus Irinotecan as Second-line Treatment in Patients With Homologous Recombination Deficiency (HRD) Metastatic Colorectal Cancer.
Fudan University
Phase 2 Unknown
NCT02789332 2020-03-17
GeparOla
GBG Forschungs GmbH
Phase 2 Completed